Connection

Piercarlo Sarzi-Puttini to Rituximab

Back to Details
This is a "connection" page, showing publications Piercarlo Sarzi-Puttini has written about Rituximab.
Piercarlo Sarzi-Puttini
Connection Strength
1.093
Rituximab
  1. Presence of specific T cell response after SARS-CoV-2 vaccination in rheumatoid arthritis patients receiving rituximab. Immunol Res. 2021 08; 69(4):309-311.
    View in: PubMed
    Score: 0.502
  2. Low Risk of Hepatitis B Virus Reactivation in HBsAg-negative/Anti-HBc-positive Carriers Receiving Rituximab for Rheumatoid Arthritis: A Retrospective Multicenter Italian Study. J Rheumatol. 2016 05; 43(5):869-74.
    View in: PubMed
    Score: 0.344
  3. Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response"by Bonelli et al. Ann Rheum Dis. 2021 10; 80(10):e166.
    View in: PubMed
    Score: 0.125
  4. Use of rituximab in a multicentre cohort of patients with rheumatic diseases during the outbreak of novel SARS-COV-2 infection. Clin Exp Rheumatol. 2021 May-Jun; 39(3):695.
    View in: PubMed
    Score: 0.122
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.